Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Faron Pharmaceuticals Ltd

Clinical trials sponsored by Faron Pharmaceuticals Ltd, explained in plain language.

Faron Pharmaceuticals Ltd FARON NASDAQ HELSINKI

A clinical-stage biopharmaceutical company focused on cancer and inflammatory diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1

New Antibody-Azacitidine combo aims to boost remission in High-Risk blood cancer

Disease control Not yet recruiting

This phase 2 trial tests whether adding bexmarilimab, an antibody that targets Clever-1, to standard azacitidine chemotherapy improves outcomes for adults with newly diagnosed higher-risk myelodysplastic syndromes (HR-MDS). Participants are randomly assigned to receive one of two…

Phase: PHASE2 • Sponsor: Faron Pharmaceuticals Ltd • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC